TrademarkDir
ABRIZYL
DEAD

Serial Number

86305053

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Jun 10, 2014

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ABRIZYL Trademark

Serial Number: 86305053

ABRIZYL is a trademark filed by NOVARTIS AG on June 10, 2014. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

June 10, 2014

Registration Date

Not Registered

Published for Opposition

August 19, 2014

Goods & Services

Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Nov 20, 2017 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Nov 20, 2017 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 15, 2017 EXRA
SOU EXTENSION 5 GRANTED
Apr 13, 2017 EX5G
SOU EXTENSION 5 FILED
Apr 8, 2017 EXT5
SOU TEAS EXTENSION RECEIVED
Apr 8, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 26, 2016 EXRA
SOU EXTENSION 4 GRANTED
Oct 25, 2016 EX4G
SOU EXTENSION 4 FILED
Oct 13, 2016 EXT4
SOU TEAS EXTENSION RECEIVED
Oct 13, 2016 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 15, 2016 EXRA
SOU EXTENSION 3 GRANTED
Apr 14, 2016 EX3G
SOU EXTENSION 3 FILED
Apr 11, 2016 EXT3
SOU TEAS EXTENSION RECEIVED
Apr 11, 2016 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 22, 2015 EXRA
SOU EXTENSION 2 GRANTED
Oct 21, 2015 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 21, 2015 AITU
SOU EXTENSION 2 FILED
Oct 12, 2015 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 12, 2015 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 10, 2015 EXRA
SOU EXTENSION 1 GRANTED
Apr 8, 2015 EX1G
SOU EXTENSION 1 FILED
Apr 8, 2015 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 8, 2015 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 14, 2014 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 19, 2014 NPUB
PUBLISHED FOR OPPOSITION
Aug 19, 2014 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 30, 2014 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 11, 2014 CNSA
ASSIGNED TO EXAMINER
Jul 10, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 19, 2014 NWOS
NEW APPLICATION ENTERED
Jun 13, 2014 NWAP

Related Trademarks

More from this Owner

VAYBETRY

VAYBETRY

JOLBETZY

JOLBETZY

BEXJUXI

BEXJUXI

VOBYXA

VOBYXA

VISANSTA

VISANSTA

VISANSTA

VISANSTA